Corticospinal tract risk modifies motor recovery after minimally invasive surgery for intracerebral hemorrhage: a secondary analysis of MISTIE-III
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Objective
Outcome after surgical hematoma evacuation for intracerebral hemorrhage (ICH) depends on hematoma location. As corticospinal tract (CST) integrity affects motor recovery after stroke, we hypothesized that CST integrity drives heterogeneity in surgical outcomes and investigated this in a secondary analysis of MISTIE-III participants.
Methods
Risk of CST injury was categorized into four levels, based on the interaction between the CST, the hematoma, and perihematomal edema (PHE) on automatically segmented stability CT: no risk, PHE infiltration, hematoma infiltration, and complete interruption of the CST. Associations with outcome were tested using multivariable linear regression for motor National Institutes of Health Stroke Scale (NIHSS) at day 180 and ordinal regression for modified Rankin Scale (mRS) at day 365, introducing an interaction term between CST risk and treatment group.
Results
Day 180 motor NIHSS was significantly lower for ‘no risk’ (b:-3.77, [95% confidence interval [CI]: -5.8 to -1.70], p =0.0003) and ‘PHE infiltration’ (b:-2.3, [95%CI: - 3.5 to -1.1]; p =0.0002) vs. ‘complete interruption’. Surgery was associated with lower Day 180 motor NIHSS in participants with hematoma infiltration (b:-2.07, [95%CI: -3.8 to -0.4], p =0.016). Compared to complete interruption, ‘no risk’ (adjusted odds ratio [aOR]:0.27, [95%CI: 0.10 to 0.74], p =0.01) and ‘PHE infiltration’ (aOR:0.41, [95%CI: 0.23 to 0.74]; p =0.003) were associated with lower odds of unfavorable day 365 mRS. Surgery was associated with lower mRS in participants with no risk (aOR:0.23, [95%CI: 0.05 to 0.97, p =0.045).
Interpretation
Increasing CST risk is associated with worse motor recovery (day 180) and disability (day 365). CST risk modifies the effect of the MISTIE-III procedure on motor recovery and disability.
Trial registration
NCT01827046 ( https://clinicaltrials.gov/study/NCT01827046 )
